Huons Biopharma
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| To Evaluate HU-045 in the Treatment of Glabellar Lines(Phase III) (NCT06205797) | Huons Biopharma | 2024-06-20 |
| To Evaluate the Efficacy and Safety of LIZTOX in Subjects with Benign Masseteric Hypertrophy (NCT05964257) | Huons Biopharma | 2023-07-25 |
Track Huons Biopharma automatically
Every clearance here is in the API, with alerts when new ones post.